First Look Analysts Research Calls for Wednesday, March 29

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
First Look Analysts Research Calls for Wednesday, March 29

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Carnival (CCL) upgraded to Positive from Neutral at Susquehanna; tgt $11

> Enbridge (ENB) upgraded to Neutral from Underperform at Credit Suisse

> Hartford Financial (HIG) upgraded to Buy from Neutral at Goldman; tgt $84

> Invesco (IVZ) upgraded to Neutral from Underperform at Credit Suisse; tgt raised to $15

> lululemon athletica (LULU) upgraded to Buy from Neutral at Citigroup; tgt raised to $440

> lululemon athletica (LULU) upgraded to Outperform from Neutral at KGI Securities; tgt $394

> Marathon Petroleum (MPC) upgraded to Buy from Neutral at Goldman; tgt raised to $150

> Nextracker (NXT) upgraded to Buy from Neutral at BofA Securities; tgt raised to $40

> Omnicom (OMC) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $96

Downgrades:

> Bath & Body Works (BBWI) downgraded to Neutral from Buy at UBS

> Burlington Stores (BURL) downgraded to Sell from Neutral at UBS

> Ciena (CIEN) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $57

> Delek US Holdings (DK) downgraded to Neutral from Buy at Goldman; tgt lowered to $24

> Foot Locker (FL) downgraded to Sell from Neutral at UBS

> Interpublic (IPG) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $40

> Macy’s (M) downgraded to Hold from Accumulate at Gordon Haskett; tgt $18

> Medtronic (MDT) downgraded to Sell from Buy at UBS; tgt lowered to $79

> Penumbra (PEN) downgraded to Hold from Buy at Needham

> Ross Stores (ROST) downgraded to Sell from Neutral at UBS

> Urban Outfitters (URBN) downgraded to Sell from Neutral at UBS

Others:

> Abbott Labs (ABT) initiated with a Buy at UBS; tgt $117

> American Homes 4 Rent (AMH) initiated with an Equal Weight at Wells Fargo; tgt $31

> AvalonBay (AVB) initiated with an Overweight at Wells Fargo; tgt $184

> Baxter (BAX) initiated with a Neutral at UBS; tgt $43

> Boston Scientific (BSX) initiated with a Buy at UBS; tgt $57

> Butterfly Network (BFLY) initiated with a Neutral at UBS; tgt $2.25

> Camden Property (CPT) initiated with an Underweight at Wells Fargo; tgt $102

> Confluent (CFLT) initiated with a Buy at Mizuho; tgt $28

> Deere (DE) initiated with an Outperform at Daiwa Securities; tgt $440

> Dexcom (DXCM) initiated with a Buy at UBS; tgt $142

> Edwards Lifesciences (EW) initiated with a Neutral at UBS; tgt $84

> Enliven Therapeutics (ELVN) initiated with a Buy at Jefferies; tgt $27

> Equity Lifestyle Properties (ELS) initiated with an Overweight at Wells Fargo; tgt $75.50

> Equity Residential (EQR) initiated with an Equal Weight at Wells Fargo; tgt $62

> Essex Property (ESS) initiated with an Underweight at Wells Fargo; tgt $208

> GitLab (GTLB) initiated with a Neutral at Mizuho; tgt $38

> Hershey Foods (HSY) initiated with an Underweight at Wells Fargo; tgt raised to $255

> InMode (INMD) initiated with a Buy at UBS; tgt $40

> Inspire Medical Systems (INSP) initiated with a Buy at UBS; tgt $300

> Intuitive Surgical (ISRG) initiated with a Neutral at UBS; tgt $278

> Invitation Homes (INVH) initiated with an Overweight at Wells Fargo; tgt $33.50

> Johnson & Johnson (JNJ) initiated with a Neutral at UBS; tgt $164

> Legend Biotech (LEGN) initiated with a Buy at H.C. Wainwright; tgt $66

> lululemon athletica (LULU) placed on Analyst Focus List at JP Morgan; tgt $430

> Mid-America Aptmt (MAA) initiated with an Equal Weight at Wells Fargo; tgt $156.50

> Playtika (PLTK) resumed with a Neutral at Goldman; tgt $12

> SEI Investments (SEIC) initiated with a Neutral at Piper Sandler; tgt $60

> Stryker (SYK) initiated with a Neutral at UBS; tgt $287

> Sun Communities (SUI) initiated with an Equal Weight at Wells Fargo; tgt $151

> Tandem Diabetes Care (TNDM) initiated with a Neutral at UBS; tgt $45

> UDR (UDR) initiated with an Overweight at Wells Fargo; tgt $44.50

> Zimmer Biomet (ZBH) initiated with a Sell at UBS; tgt $112

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618